NRP1 and neoplasm: Several strategies have been explored to counteract the tumor promoting effects of NRP-1 function, employing different tools (Figure 1): recombinant sNRP-1, class 3 semaphorins, monoclonal antibodies (mAbs), peptides and peptidomimetics, small interfering RNAs (siRNAs) or microRNAs.